How many patents does
Biogen Idec Ma have?
patents
4,899
families
470
granted
1,166
applications
3,733
US
953
EP
698
JP
354
WO
273
CN
220
KR
91
RoW
2,310
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Biogen Idec Ma
Top ten assignees appearing on patents
2009 - 2018
| biogen idec ma | 2878 |
| biogen ma | 852 |
| sunesis pharmaceuticals | 200 |
| syntonix pharmaceuticals | 93 |
| biogen | 91 |
| biogen hemophilia | 90 |
| bioverativ therapeutics | 83 |
| elan pharmaceuticals | 78 |
| millennium pharmaceuticals | 64 |
| genentech | 54 |
2009
| biogen idec ma | 471 |
| syntonix pharmaceuticals | 24 |
| sunesis pharmaceuticals | 15 |
| biogen | 14 |
| nsgene | 10 |
| idec pharmaceuticals corporation | 8 |
| curis | 5 |
| fumapharm | 5 |
| dyax corporation | 5 |
| ucb pharma | 5 |
Biogen Idec Ma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| methods for chemically synthesizing immunoglobulin chimeric proteins | 76 | 2003 |
| combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibo… 🛈 | 64 | 1998 |
| antibodies against fcrn and use thereof | 58 | 2008 |
| factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof | 54 | 2009 |
| sp35 antibodies and uses thereof | 53 | 2007 |
| s1p modulating agents | 51 | 2011 |
| bicyclic aryl sphingosine 1-phosphate analogs | 50 | 2009 |
| tweak binding antibodies | 49 | 2005 |
| clotting factor-fc chimeric proteins to treat hemophilia | 48 | 2003 |
| heterocyclic compounds useful as pdk1 inhibitors | 45 | 2009 |